Health Condition 1: G560- Carpal tunnel syndrome
Conditions
Interventions
Intervention1: INTRAMUSCULAR CORTICOSTEROID INJECTION: Patients in this group will be given three intramuscular injections of depo-methylprednisolone 1 ml (40mg) given intramuscular in the deltoid mus
Sponsors
NIL
Eligibility
Inclusion criteria
Inclusion criteria: • Subjects satisfying the clinical and electrodiagnostic criteria for carpal tunnel syndrome. CTS-6 EVALUATION TOOL: A)Symptoms and History: 1.Numbness predominantly or exclusively in the median nerve territory- 3.5 2.Nocturnal numbness- 4 B)Physical examination: 3.Thenar atrophy and/or weakness- 5 4.Positive Phalenâ??s test- 5 5.Loss of 2-point discrimination- 4.5 6.Positive Tinel sign- 4 Total- 26 ELECTRODIAGNOSTIC CRITERIAS FOR CARPAL TUNNEL SYNDROME: A.Distal medial motor latency >4.4ms. B.Difference between distal motor latency of median and ulnar nerve >1.1ms. C.Difference between distal sensory latency of median and ulnar nerve >0.2ms. D.i. Difference between median and ulnar sensory latency on stimulating 4th digit and recording from wrist at equal distance >0.2ms. ii.Difference between median and radial sensory latency on stimulating thumb and recording from wrist at equal distance >0.4ms. E.Palm wrist conduction: difference between median and ulnar sensory latency across 8cm >0.4ms. F.Inching technique: latency jump >0.2ms/cm. G.Comparison of lumbricals (median nerve) and interosseous (ulnar nerve) latencies >=0.6ms • Subjects willing to provide informed written consent
Exclusion criteria
Exclusion criteria: Subjects will not participate in the study if they meet any of the following criteria: 1.Uncontrolled diabetes mellitus 2.Hypothyroidism 3.Inflammatory arthritis 4.Pregnancy 5.History of previous wrist fracture.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in Symptom Severity Scale (SSS) score from baseline to 6 months.Timepoint: 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Change in Symptom Severity Scale (SSS) score at 1 month 2. Change in Symptom Severity Scale (SSS) score at 3 months. 3. Change in Functional status scale (FSS) score and NCS findings at 1 month. 4. Change in Functional status scale (FSS) score and NCS findings at 3 months 5. Change in Functional status scale (FSS) score and NCS findings at 6 months. 6. Requirement of surgery for flexor retinaculum release at 6 months. 7. Adverse effects of steroid injections at 6 months.Timepoint: 6 months | — |
Countries
India
Contacts
Public ContactDr Jagbir saini
AIIMS Rishikesh
Outcome results
None listed